Blog

January 25, 2019

Secret Sales Remain Prior Art Under the AIA: Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc.

Read More
January 9, 2019

When Double Patenting Rejections are Not Obvious: Novartis v. Breckenridge and Novartis v. Ezra

Kirsten Johnson
Read More
November 7, 2018

Patent Strategies for Beta Testing: Leveraging Provisional Patent Applications to Preserve Patent Rights for Beta Features

Aaron Johnson
Read More
October 11, 2018

PTAB Revises Claim Construction Standard

Dinesh N. Melwani
Read More
October 4, 2018

PTAB Publishes AIA Trial Practice Guide Update

Jason B. Portis
Read More
June 21, 2018

Patent-Eligibility of “Methods of Treatment,” and Possible Movement Toward Greater Eligibility

Aaron Johnson
Read More
May 2, 2018

Supreme Court Strikes Down PTAB Partial-Institution Practice—SAS Institute v. Iancu

Read More
April 20, 2018

USPTO Releases Updated Patent-Eligibility Guidance Favorable to Patent Applicants

Chris Agrawal
Read More
April 19, 2018

Hope for Clarification of the On-Sale Bar on the Horizon

Jessica F. Winchester
Read More
April 12, 2018

PTAB to Reconsider its Indefiniteness Standard?

Read More